EUVIMEDEUVIMED entdecken
CrossrefInfokarte

5T‐Based Glutamate Chemical Exchange Saturation Transfer Imaging for Adult Diffuse Glioma Stratification

Yinwei Ying, Qihang Yu, Yan Ren, Yajing Zhao, Dongdong Wang, Nan Mei, Zhuoying Ruan, Yuxi Xie, Jie Chen, Jin Cui, Jiayun Pan, Kai Lu, Zhiwei Qin, Yiping Lu, Bo Yin

Journal of Magnetic Resonance Imaging · 2026-08 · 64 (2) · 415-426

DOI: 10.1002/jmri.70340 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Background Glutamate chemical exchange saturation transfer (GLU‐CEST) is a non‐invasive in vivo approach for glutamate detection, but its performance for glioma evaluation at 5T remains incompletely defined. Purpose To investigate factors influencing 5T GLU‐CEST and its diagnostic value in glioma stratification. Study Type Prospective. Phantom and Population Five phantom series (pH 6.2–7.4; glutamate 8–20 mM) and 40 adult‐type diffuse glioma patients (49.00 ± 12.26 years; 23 males). Fieldstrength/Sequence 5 T, fast spin‐echo GLU‐CEST and amide proton transfer (APT)‐CEST. Assessment Phantoms and patients underwent MRI scans; GLU‐CEST, APT‐CEST, and normalized values (ΔGLU‐CEST, ΔAPT‐CEST) were quantified. Gliomas were graded by WHO 2–4; IDH status was determined. Statistical Tests Spearman correlation, Kruskal–Wallis tests, Mann–Whitney U tests, and weighted DeLong tests; two‐sided p < 0.05 was significant. Results GLU‐CEST signals positively correlated with glutamate and negatively with pH ( ρ ≥ 0.893). Significant differences were found in all effects between WHO Grade 2 and 4 gliomas (ΔGLU‐CEST: 2.006 [1.143, 2.799] vs. 4.365 [2.974, 5.299]; GLU‐CEST: 7.424 [6.679, 7.649] vs. 10.155 [8.098, 11.550]; ΔAPT‐CEST: 1.918 [1.258, 2.461] vs. 3.386 [2.682, 4.805]; APT‐CEST: 1.961 [1.425, 2.715] vs. 3.333 [2.478, 4.632]), whereas only ΔGLU‐CEST and GLU‐CEST exhibited significant disparities between Grade 3 and 4 gliomas (ΔGLU‐CEST: 2.171 [1.895, 2.862] vs. 4.365 [2.974, 5.299]; GLU‐CEST: 7.102 [6.475, 7.259] vs. 10.155 [8.098, 11.550]). In the solid tumor region, all effects demonstrated significant differences between IDH‐mutant and IDH wild‐type gliomas (ΔGLU‐CEST: 2.111 [1.614, 3.110] vs. 4.333 [2.964, 5.405]; GLU‐CEST: 7.259 [6.577, 7.726] vs. 10.291 [8.097, 11.634]; ΔAPT‐CEST: 2.017 [1.355, 2.718] vs. 3.235 [2.670, 4.735]; APT‐CEST: 2.122 [1.680, 2.889] vs. 3.270 [2.450, 4.262]), whereas GLU‐CEST outperformed APT‐CEST and ΔAPT‐CEST in diagnostic efficacy (AUC difference = 0.073 and 0.101). Data Conclusion 5 T GLU‐CEST is capable of differentiating between grade 2 and grade 4, as well as grade 3 and grade 4 adult diffuse gliomas, and demonstrates superior performance to APT‐CEST in the classification of IDH status. Evidence Level 2. Technical Efficacy Stage 2.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →